<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3018">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01709201</url>
  </required_header>
  <id_info>
    <org_study_id>FP01009751</org_study_id>
    <nct_id>NCT01709201</nct_id>
  </id_info>
  <brief_title>Reducing Problematic Substance Use in Youth With Chronic Medical Conditions</brief_title>
  <official_title>Reducing Problematic Substance Use in Youth With Chronic Medical Conditions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Boston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital Boston</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators goal is to pilot a substance use-related brief intervention (BI) for youth
      with chronic medical conditions, obtaining preliminary evidence of feasibility,
      acceptability and impacts of the approach for reducing substance use among this group.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Percent days abstinent</measure>
    <time_frame>30 days post baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will compare the percent days abstinent from substances between the Treatment as Usual and Intervention groups 30 days post baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Medical complications</measure>
    <time_frame>30 days post baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will evaluate the incidents of disease complications between the Treatment as Usual and Intervention groups 30 days post baseline</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Percent Days Abstinent 90 days post baseline</measure>
    <time_frame>90 days post baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will compare the percent days abstinent from substances between the Treatment as Usual and Intervention groups 90 days post baseline</description>
  </other_outcome>
  <other_outcome>
    <measure>Medical complications 90 days post baseline</measure>
    <time_frame>90 days post baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will evaluate the incidents of disease complications between the Treatment as Usual and Intervention groups 30 days post baseline</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Alcohol Abuse</condition>
  <condition>Drug Abuse</condition>
  <arm_group>
    <arm_group_label>Treatment as Usual</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Those in the Treatment as Usual group will not receive the brief intervention for substance use but will receive a brief health education brochure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Brief Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Those in the Brief Intervention group will receive a brief motivational intervention aimed at encouraging the participant to decrease their substance use.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Brief Intervention</intervention_name>
    <description>Those in the intervention arm will undergo a 10-minute discussion with a trained interventionist aimed at encouraging decreased substance use.</description>
    <arm_group_label>Brief Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  14-18 years old

          -  Currently being treated for diabetes, rheumatologic disorders, asthma, or ulcerative
             colitis (UC) at Boston Children's Hospital with a duration of chronic illness of at
             least one year

          -  Previous participation in the screening validation study

          -  Evidence of problems related to substance use

        Exclusion Criteria:

          -  Medically or emotionally unstable or otherwise unable to provide assent/consent

          -  Unable to speak/read English

          -  Unable to use a computer keyboard and/or complete an interviewer-assisted
             questionnaire
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sharon Levy, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Boston</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elissa Weitzman, ScD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Boston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sharon Levy, MD</last_name>
    <phone>617-355-5433</phone>
    <email>sharon.levy@childrens.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shari Van Hook, MPH</last_name>
    <phone>617-355-5433</phone>
    <email>shari.vanhook@childrens.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 2, 2013</lastchanged_date>
  <firstreceived_date>October 15, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alcohol abuse</keyword>
  <keyword>Drug abuse</keyword>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Persistent Asthma</keyword>
  <keyword>Juvenile Arthritis</keyword>
  <keyword>Ulcerative Colitis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
